{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-103747","form_type":"8-K","ticker":"DERM","cik":"0001867066","company_name":"Journey Medical Corp","filed_at":"2023-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.919493+00:00","generated_at":"2026-06-10T08:56:21.854949+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Journey Medical regains Nasdaq compliance with stockholders' equity rule","bullets":["Previously notified Aug 15, 2023 of non-compliance with Nasdaq minimum $2.5M stockholders' equity.","Received $19M upfront payment from license agreement on Aug 31, 2023 to address deficiency.","On Sep 20, 2023, Nasdaq Staff confirmed the company meets the Stockholders' Equity Requirement.","Company remains listed on Nasdaq Capital Market; delisting risk removed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-103747","json":"https://secwatch.observer/filing/0001104659-23-103747.json","markdown":"https://secwatch.observer/filing/0001104659-23-103747.md","text":"https://secwatch.observer/filing/0001104659-23-103747.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923103747/0001104659-23-103747-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923103747/tm2326916d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T08:56:21.854949+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}